spacer
home > pmps > summer 2007 > making gas a quality issue
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Making Gas a Quality Issue

As the drive for quality continues, regulatory framework surrounding emissions control tightens. Lieve de Paepe at Air Products urges the pharmaceutical industry to foster close partnerships with suppliers to achieve compliance and improve efficiency

Generally used for only the most demanding industrial applications, pharmaceutical manufacturers use speciality gases for a wide range of specialist applications. These applications range from environmental monitoring and control, to using the gas as a key component of the production process itself. For example, many manufacturers use nitrogen as an inerting gas to prevent chemical reactions during production and packaging processes. At other times, pure gases, such as oxygen, are used to create the required reactions or to encourage microbe culture growth. Speciality gases are commonly used in the laboratory and in the area of R&D, and can even be used to carry out specific production processes, such as chemical synthesis. With such critical uses in mind, demand for quality has never been higher, and manufacturers need to be sure that the gas products they are using will deliver the highest standards of accuracy and consistency.

SOURCING HIGH GRADE GASES

When sourcing the highest grade speciality gases, first and foremost manufacturers tend to select those that fulfil the requirements of the monographs of the European, US and Japanese Pharmacopoeias. These standards are widely recognised by manufacturers and gas suppliers alike. In addition, the recent introduction of directives 2004/27/EC and 2004/28/EC (amending directives 2001/83/EC and 2001/82/EC), concerning the use of active pharmaceutical ingredients (API) for human and veterinary use, requires manufacturers to provide an assurance of quality and traceability at every stage of the production process – from R&D, through to production and analysis. As part of this requirement, manufacturers must use high grade speciality gases, which have been produced according to good manufacturing practice (GMP) part II.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
4
     

There are no comments in regards to this article.

 You must be a member of the site to make a comment.
spacer
Lieve de Paepe joined Air Products in 1990 after graduating as a Chemical Engineer from the University of Ghent, Belgium. In her current role, Lieve is responsible for supporting the development of speciality gases for a wide range of industrial applications in the pharmaceutical, chemical and environmental management sectors.
spacer
Lieve de Paepe
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Sphere Fluidics Closes a $4.8 million USD (£3.7 million) Funding Round

Cambridge, UK, 10 June 2019: Sphere Fluidics, a company commercializing single cell analysis systems underpinned by its patented picodroplet technology, announced today that it has closed an additional tranche of investment of $2.9 million (£2.2 million), securing a total of $4.8 million (£3.7 million) in investment. The funding will be used as working capital for the Company’s Cyto-Mine® Single Cell Analysis System, expansion of the UK facility and enable the doubling of personnel through the opening of a new US Sales Office and Demo Lab in California.
More info >>

White Papers

Faster, Better, Cheaper: Lean as a Driving Force Behind Pharmaceutical Companies’ Growth

TBM Consulting Group

The pharmaceutical industry faces countless challenges: patent expirations, weak product development pipelines, downward pricing pressure and an increasingly burdensome regulatory environment. The most important question for companies is now “How can we position ourselves optimally to be successful in the long term?” Some pharmaceutical companies used the economic downturn in 2009 to embrace measures in the fields of cost reduction and efficiency increases, which can be implemented at short notice. The continuous and consistent implementation of sustainable measures that guarantee stability and form the basis for future growth was not necessarily paramount within this.
More info >>

 
Industry Events

FlyPharma Europe

22-23 October 2019, Copenhagen, Denmark

The FlyPharma Conference Europe 2019 is aimed at forward-thinking individuals and businesses that are ready to uncover the potential in their pharma supply chain. The event offers an interactive platform to discuss current and future challenges within pharma and cargo, with topics including market trends, cold chain innovations, latest regulatory demands, security technology, and how to encourage collaboration between supply chain players. There will be plenty of networking opportunities, including a complimentary evening networking event, where delegates can meet and catch up with senior and executive pharma and cargo professionals – gaining strong, new industry contacts and building on existing ones.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement